In this episode Dr. Stader and Dr. Bradley summarize and offer key insights for the following Coaches Top 5 picks, discussing buprenorphine vs methadone treatment for OUD, the link between gabapentinoids and COPD exacerbations, the significant decrease in overdose mortality rates seen in Sweden after rolling out take-home naloxone, and more!
Gabapentinoids and Risk for Severe Exacerbation in Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study, Published in the Annals of Internal Medicine, January 2024
Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies Published in the Lancet Journal of Psychiatry- May 2023
Addressing the Spectrum of Opioid Misuse Prevention, Treatment, and Recovery in Rural Washington State Communities: Provider Identified Barriers and Needs Published in the Community Mental Health Journal, January 2024
Distribution of intranasal naloxone to potential opioid overdose bystanders in Sweden: effects on overdose mortality in a full region-wide study Published in the BMJ Open, January 2024
Association of therapies with reduced pain and improved quality of life in patients with fibromyalgia: a systematic review and meta-analysis Published in JAMA Internal Medicine, January 2021
